Sector ratings Harmony Biosciences Holdings, Inc.

Equities

Market Closed - Nasdaq Other stock markets 04:00:00 2025-01-15 pm EST			5-day change	1st Jan Change
36.93 ^USD	+1.40%		+6.95%	+7.32%

Jan. 15	Harmony Biosciences Holdings, Inc. Presents at 43rd Annual J.P. Morgan Healthcare Conference 2025, Jan-15-2025 11:15 AM
Jan. 13	Harmony Biosciences Reports Preliminary Q4, 2024 Net Product Revenue; 2025 Revenue Guidance Issued	MT

Sector:

Location:

X axis:

Main competitors

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	ESG MSCI	Capi. ($)
HARMONY BIOSCIENCES HOLDINGS, INC.	BB	2.11B
ELI LILLY AND COMPANY	A	672B
NOVO NORDISK A/S	AAA	371B
JOHNSON & JOHNSON	A	349B
ABBVIE INC.	A	303B
MERCK & CO., INC.	A	253B
ROCHE HOLDING AG	A	234B
ASTRAZENECA PLC	AA	202B
NOVARTIS AG	AA	198B
PFIZER, INC.	A	149B
AMGEN INC.	A	145B
SANOFI	BBB	123B
GILEAD SCIENCES, INC.	AAA	115B
BRISTOL-MYERS SQUIBB COMPANY	A	113B
CHUGAI PHARMACEUTICAL CO., LTD	AA	70.53B
GSK PLC	AA	66.29B
DAIICHI SANKYO CO., LTD.	AAA	49.05B
TAKEDA PHARMACEUTICAL COMPANY LIMITED	A	41.49B
HALEON PLC	A	40.66B
Average	AA	184.08B
Weighted average by Cap.	AA